U.S. Pharmacopeia CEO and leadership

Q: Who is the CEO of U.S. Pharmacopeia?

The CEO of U.S. Pharmacopeia is Ronald T. Piervincenzi.

Zippia score 4.8

U.S. Pharmacopeia CEO and executives

Executive Summary. Based on our data team's research, Ronald T. Piervincenzi is the U.S. Pharmacopeia's CEO. U.S. Pharmacopeia has 750 employees, of which 29 are in a leadership position.

Here are further demographic highlights of the leadership team:

The U.S. Pharmacopeia executive team is 41% female and 59% male.
51% of the management team is White.
14% of U.S. Pharmacopeia management is Hispanic or Latino.
13% of the management team is Black or African American.

Work at U.S. Pharmacopeia?

Share your experience

Rate U.S. Pharmacopeia's leaders' effectiveness in guiding the company.

Name & TitleBio

Ronald T. Piervincenzi

CEO

Ronald Piervincenzi is a Chief Executive Officer at United States Pharmacopeia and is based in Rockville, Maryland. He has worked as Principal at McKinsey & Company and VP Development Sciences Business Strategy at BIOGEN INC.. Ronald studied at Hofstra University between 1989 and 1993 and Duke University between 1993 and 2000.

Jaap Venema

Executive Vice President & Chief Science Officer

Stan Burhans

CFO

A global finance executive with extensive experience in business operations and public company governance, valued for the ability to assume leadership roles in growth initiatives and enterprise priorities. Over 20 years of international experience living and working in Germany and Japan and conducting business in Europe, China, India, Asia and Latin America. An established record of streamlining business process and achieving cost savings. Accomplished at strategic planning, leading cross-functional teams and delivering results. Serves as trusted advisor to CEO, CFO and the senior leadership team.

Select Career Highlights:

• Held several Finance Executive roles, including CFO, Commercial Operations, Controller and Treasurer. Served as Finance Director in Japan, Germany and US. Began career with Columbia MBA and CPA at Deloitte.

• Led a worldwide finance team of 350 professionals supporting business operations in over 50 countries.

• Responsible for the MJN IPO, a $7B subsidiary of BMS, including the prospectus, carve-out financials, due diligence, separation activities, transition services and start-up of independent operations.

• Implemented a global SAP/ERP system, built External Reporting and Financial Shared Service functions.

• Leader of corporate decision-making bodies responsible for financial statement disclosure, capital spending, IM strategy, productivity, working capital, commodities, and pension and benefits.

• Led multiple enterprise growth initiatives, including acquisitions, divestitures, joint ventures, organic market entries and capacity investments.

Competencies:

Strategic Planning, Financial Analysis, Forecasting,

SEC and Financial Reporting

Internal Controls, Sarbanes-Oxely, Audit,

SAP, ERP Implementation, IT Management,

Acquisitions, Divestitures, Valuation, IPO, Due Diligence,

Treasury, Cash Management, Tax Planning,

Investor Relations, Rating Agencies,

Supply Chain, Manufacturing, Marketing Finance,

Team Leadership, Career Development

Bruk Alemayehu

Senior Vice President

Christine E. Feaster

Vice President

Debra Joy Pérez

Chief Equity Officer

Dennis R. Hall

Vice President

Emily Kaine

Senior Vice President

Fouad Atouf

Vice President

Gersande Chavez

Vice President

Do you work at U.S. Pharmacopeia?

Does leadership effectively guide U.S. Pharmacopeia toward its goals?

U.S. Pharmacopeia jobs

U.S. Pharmacopeia board members

Name & TitleBio

Debra Joy Pérez

Chief Equity Officer

Alessandro Slama

Board Member

Anthony Tann

Board Member

Nilton Tojar Sr

Board Member

U.S. Pharmacopeia leadership demographics

U.S. Pharmacopeia gender distribution in management team

The U.S. Pharmacopeia executive team is 41% female and 59% male.
U.S. Pharmacopeia is 41% female and 59% male company-wide.

Male

59%

Company-wide: 59%

Female

41%

Company-wide: 41%

U.S. Pharmacopeia executives by race

Management Team:

The most common ethnicity among U.S. Pharmacopeia executive officers is White.
51% of the management team is White.
15% of U.S. Pharmacopeia's management is Asian.
14% of the management team is Hispanic or Latino.

Company-wide:

White is the most common ethnicity company-wide.
47% of employees are White.
23% of employees are Black or African American.
13% of employees are Asian.

Management team
General

100%

80%

60%

40%

20%

Unknown

White

Black or African American

Asian

Hispanic or Latino

U.S. Pharmacopeia jobs nearby

U.S. Pharmacopeia executives FAQs

Who is the CEO of U.S. Pharmacopeia?

Related company executives

Working at related companies

Related company jobs

U.S. Pharmacopeia highest paying jobs

Companies
Maryland
Rockville, MD
U.S. Pharmacopeia
U.S. Pharmacopeia Executives

Updated November 18, 2022

Zippia gives an in-depth look into the details of U.S. Pharmacopeia, including salaries, political affiliations, employee data, and more, in order to inform job seekers about U.S. Pharmacopeia. The employee data is based on information from people who have self-reported their past or current employments at U.S. Pharmacopeia. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by U.S. Pharmacopeia. The data presented on this page does not represent the view of U.S. Pharmacopeia and its employees or that of Zippia.

U.S. Pharmacopeia may also be known as or be related to The United States Pharmacopeial Convention Inc, The United States Pharmacopeial Convention, Inc., U.S. Pharmacopeia, U.S. Pharmacopeial Convention (The United States Pharmacopeial Convention), U.s. Pharmacopeia, United States Pharmacopeia and United States Pharmacopeial Convention.